Use of Bisphosphonate and Risk of Incident Atrial Fibrillation in a Population-Based Study

Oct-17

AUTHORS : Dr Shanshan Sheehy (Publish under Shanshan Li), Boston University, 650 Albany St, Evans Biomed Research Ctr, Boston MA 02118 – Email: shl607@bu.edu – Profile: https://profiles.bu.edu/Shanshan.Sheehy AND https://www.bumc.bu.edu/busm/profile/shanshan-sheehy/ OR Dr Tuhina Neogi, Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, 650 Albany St, X Bldg, Ste 200, Boston, MA 02118 – Email: tneogi@bu.edu – Profile: https://www.bumc.bu.edu/busm/profile/tuhina-neogi/

JOURNAL : Arthritis & Rheumatology

REFERENCE: 69(S10)

DOI : 10.1002/art.40321

Use of Bisphosphonate and Risk of Incident Atrial Fibrillation in a Population-Based Study

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study